Omics-driven insights into tumor microenvironment determinants of immunotherapy response in melanoma
Immunotherapy has revolutionized cancer treatment, yet response rates remain highly variable across tumor types and individual patients. Increasing evidence ...
In recent years, innovative cancer drugs that target specific molecular drivers of the disease have been embraced as the treatment of choice for many types of cancer. But despite significant advances, ...
What drives tumor growth? Is it a few rogue cells imposing their will upon healthy tissue, or diseased tissue bringing out the worst in otherwise peaceable cells? Or is it a back-and-forth, a dialogue ...
MILAN — Is chronic lymphocytic leukemia (CLL) progression primarily driven by genetic mutations or by external cues from the tumor microenvironment? Despite major strides in targeted therapies, CLL ...
ROCKVILLE, Md.--(BUSINESS WIRE)--The National Foundation for Cancer Research (NFCR) announced today that Isaac P. Witz, Ph.D., has been selected to receive the 2023 Szent-Györgyi Prize for Progress in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results